NBY Financial Facts

Basic and diluted (in Dollars per share): -0.34
Other revenues: 176K
See Full Income Statement

Prepaid expenses and other current assets: 1.83M
Total stockholders' equity: 6.72M
See Full Balance Sheet

NovaBay Pharma (NBY) Earnings

  |   Expand Research on NBY
Next EPS Date 8/6/21 *Est. EPS Growth Rate N/A
Average EPS % Beat Rate -33.9% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS -3.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/6/21 Q121 N/A-$0.04 N/A N/A$2.34M N/A N/A N/A
3/25/21 Q420 -$0.04-$0.04 $0.00$1.9M$2.48M N/A Details
11/12/20 Q320 -$0.08N/A N/A $2.2M$1.62M N/A Details
8/6/20 Q220 N/A-$0.05 N/A N/A$2.85M N/A N/A N/A
5/7/20 Q120 N/A-$0.07 N/A N/A$2.09M N/A N/A N/A
3/26/20 Q419 -$0.13-$0.07 -$0.06$1.7M$2.07M N/A Details
11/7/19 Q319 N/A-$0.08 N/A N/A$2.05M N/A N/A N/A
7/29/19 Q219 $0.00N/A N/A $1.8M$1.53M N/A Details